Heart failure revascularisation
ISRCTN | ISRCTN86284615 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN86284615 |
Secondary identifying numbers | G9900791 |
- Submission date
- 18/10/2000
- Registration date
- 18/10/2000
- Last edited
- 16/05/2011
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Professor John GF Cleland
Scientific
Scientific
Academic Unit of Cardiology
University of Hull
Castle Hill Hospital
Cottingham
Kingston-upon-Hull
HU16 5TX
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | |
Study objectives | To determine whether coronary revascularisation, improves the survival of patients with heart failure due to coronary disease who have evidence of dysfunctional but viable myocardium or stress-induced ischaemia (but who do not require revascularisation for the relief of angina) and who are receiving optimal medical treatment. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Heart failure with left ventricular systolic dysfunction |
Intervention | Best medical therapy versus best medical therapy and revascularisation |
Intervention type | Other |
Primary outcome measure | All-cause mortality |
Secondary outcome measures | 1. All-cause mortality or myocardial infarction more than 72 hours from coronary revascularisation 2. All-cause mortality and all-cause hospitalisation 3. All-cause mortality and unplanned cardiovascular hospitalisation 4. Days alive and out of hospital 5. Death, non-fatal myocardial infarction or non-fatal stroke 6. Symptom scores for angina and heart failure 7. Quality of life (using EuroHeart Failure, EQ-5D and Minnesota Living with Heart Failure Questionnaires) 8. Mean cost of Therapy (a health economic outcome) |
Overall study start date | 01/01/2002 |
Completion date | 30/09/2011 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Not Specified |
Target number of participants | 800 |
Key inclusion criteria | 1. Heart failure (in the investigators' opinion) with left ventricular systolic dysfunction (ejection fraction less than 35%) requiring chronic diuretic therapy 2. Coronary disease as the cause of heart failure as evidenced by a history of previous myocardial infarction, previous revascularisation or previous angiography 3. Stress-induced myocardial ischaemia or evidence of myocardial hibernation/stunning affecting five or more left ventricular segments in a 16-segment model. The core laboratories will make the decision about whether the test identifies a sufficient volume of affected myocardium |
Key exclusion criteria | 1. Patients who are not candidates for Coronary Artery Bypass Graft (CABG) because of frailty or serious co-morbidity (eg:- severe lung disease, metastatic carcinoma) 2. Unstable angina, myocardial infarction or stroke within the preceding two months 3. Inability to give written informed consent 4. Unwilling to consent to being contacted directly by staff at the data centre or unwilling to allow their hospital notes to be copied and sent to the data centre 5. Patients being considered for revascularisation for the relief of chest pain (angina) or valve surgery 6. Patients involved in another randomised controlled trial |
Date of first enrolment | 01/01/2002 |
Date of final enrolment | 30/09/2011 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Academic Unit of Cardiology
Kingston-upon-Hull
HU16 5TX
United Kingdom
HU16 5TX
United Kingdom
Sponsor information
Medical Research Council (MRC) (UK)
Research council
Research council
20 Park Crescent
London
W1B 1AL
United Kingdom
Phone | +44 (0)20 7636 5422 |
---|---|
clinical.trial@headoffice.mrc.ac.uk | |
Website | http://www.mrc.ac.uk |
Funders
Funder type
Research council
Initial funding provided by the Medical Research Council (UK).
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 01/06/2003 | Yes | No | |
Results article | results | 01/02/2011 | Yes | No |